"DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants" by Jack Reilly

Selected Works of Jack Reilly

Follow Contact

Article

DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants

Future Medicine (2023)

Jack Reilly, Western University

Link

Disciplines

Pediatrics

Publication Date

2023

Citation Information

Jack Reilly. "DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants" Future Medicine (2023)
Available at: http://works.bepress.com/jack-reilly/11/